Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
brain disease
Biotech
Recursion's brain disease trial shows scant evidence of efficacy
Recursion has stumbled through an early test of its tech-enabled drug discovery, reporting a hit on safety but failing to wow on the efficacy front.
Nick Paul Taylor
Sep 3, 2024 10:30am
Super-fit mice reveal anti-inflammatory brain protein
Dec 10, 2021 8:40am
Brain atlas unveils dozens of cell types that control movement
Oct 11, 2021 8:44am
Omniscient Neurotechnology rakes in $29M for brain-mapping tech
Jul 20, 2021 9:45am
Ovid plans to shop with Takeda bucks after shedding lead asset
Apr 22, 2021 9:50am
New approaches to treating brain diseases via the microbiome
Mar 15, 2021 8:20am